Teva Pharmaceutical Credit Rating Raised by S&P, Moody's Upgrades Outlook
I'm PortAI, I can summarize articles.
Teva Pharmaceutical Industries' credit rating was upgraded by S&P to BB+ and Moody's revised its outlook to positive, citing improved operating performance, debt reduction, and product launch momentum. Shares rose 1% pre-bell.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments